** Australian healthcare stocks .AXHJ fall as much as 1.4% - biggest intraday pct decline since June 23
** U.S. President Donald Trump says he will announce tariffs on pharmaceutical imports potentially at the end of July, starting with a 'low tariff' to give companies time to move their manufacturing units to the U.S. before imposing a 'very high tariff' in a year or so
** Australian pharmaceutical firms benefit significantly from U.S. sales
** Sector giant CSL CSL.AX falls 1.8% while Telix Pharmaceuticals TLX.AX down 0.7%
** Sub-index down 5.8% YTD vs 4.9% in broader benchmark .AXJO
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.